SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.61-0.6%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: david james who wrote (675)2/21/2000 1:11:00 AM
From: Don England  Read Replies (1) of 52153
 
david, this is quite a regular question in eln circles. while it may not be purely biotech itself it holds large stakes in many bios: if memory serves me something like 17% of lgnd and 5% of cyto. many others, too, which, on paper at least, equals cash, and it sits on almost a billion in real cash. doesn't seem to matter at all to the market. while eln holders like the co.s position there hasn't been much profit in it yet - those in earlier with a low cost-basis might argue that point. don
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News